Glucagon-like peptide-1 receptor agonist was not associated with an increased rate of pancreatitis in patients with T2D or obesity.
Supplemental multicancer early detection testing was linked to increases in stage I, II, and III and decreases in stage IV diagnoses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback